We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CMS DENIES BROAD PLAN TO CURB OFF-LABEL COVERAGE
CMS DENIES BROAD PLAN TO CURB OFF-LABEL COVERAGE
January 30, 2004
The Centers for Medicare & Medicaid Services (CMS) is considering denying coverage for unapproved uses of two cancer drugs, but an agency spokesman said Friday that the pending review is not part of a wider agenda to curtail Medicare coverage of widespread, but unapproved, drug treatments.